In clinical trials, the mean maximum systolic blood pressure increase was approximately 6 mmHg , typically occurring 12 hours post-injection and resolving within 12 hours
Orforglipron, if successful, could broaden access and sharpen competition in one of pharmas hottest markets, pressure already visible as Novo announced 9,000 job cuts amid intensifying rivalry
[1] [3] Secondary carnitine deficiencies may happen as the result of certain disorders, such as chronic kidney failure, or under conditions that reduce carnitine absorption or increase its excretion, such as the use of antibiotics, malnutrition, and poor absorption following digestion
Still, as mentioned, plenty of people with PCOS have overlap with conditions GLP-1s are approved for, namely diabetes or obesity
Including a literal spread sheet of other medical issues I need to get to someday when I rehab my brain as I am literally cognitively disabled and can't work
Cagrilintide - a long-acting amylin analogue that aids weight loss by further suppressing appetite, slowing gastric emptying, and modulating post-meal glucose rises